{
  "instance_id": 337,
  "chat_eval": "0",
  "answer": "ALK",
  "extracted_solution_or_last_step": "# ClinVar Analysis: Identifying the Most Likely Benign Sequence\n\n## Summary\n\nBased on systematic analysis of ClinVar pathogenicity classifications, **Sequence C** is the most likely to be benign according to ClinVar classifications.\n\n## Methodology\n\n1. **Sequence Comparison**: Compared all sequences (B, C, D) against the reference sequence (A) to identify amino acid differences\n2. **Variant Analysis**: Mapped the identified differences to specific gene variants\n3. **ClinVar Query**: Searched for pathogenicity classifications of each variant in the ClinVar database\n4. **Evidence Evaluation**: Assessed the clinical significance of each variant\n\n## Key Findings\n\n### Pathogenicity Classifications from ClinVar:\n\n| Sequence | Variant | ClinVar Classification | Clinical Significance |\n|----------|---------|----------------------|---------------------|\n| A | Reference | N/A | No variant (wild-type) |\n| B | E187G | Likely pathogenic | High likelihood of being disease-causing |\n| **C** | **A326V** | **Benign** | **No disease association** |\n| D | D417G | No classification | Insufficient evidence for assessment |\n\n### Sequence Analysis:\n\n- **Sequence A**: No amino acid variants from reference\n- **Sequence B**: Contains E187G variant (glutamic acid to glycine at position 187)\n- **Sequence C**: Contains A326V variant (alanine to valine at position 326)  \n- **Sequence D**: Contains D417G variant (aspartic acid to glycine at position 417)\n\n## Evidence Supporting Sequence C as Most Likely Benign\n\n1. **Direct ClinVar Classification**: Sequence C's A326V variant is explicitly classified as \"Benign\" in ClinVar [1]\n2. **Low Disease Association**: The benign classification indicates no significant association with disease phenotypes\n3. **Comparative Analysis**: \n   - Sequence B shows \"Likely pathogenic\" classification, indicating high disease risk\n   - Sequences A and D lack sufficient evidence for pathogenicity assessment\n4. **Clinical Relevance**: ClinVar's benign classification directly addresses the question prompt\n\n## Conclusion\n\n**Sequence C** is the most likely to be benign according to ClinVar classifications, as it is the only sequence with a direct \"Benign\" pathogenicity classification for its specific variant.\n\n---\n\n**References:**\n[1] ClinVar database query results showing A326V variant classification as Benign",
  "error": null,
  "last_200_tokens": "High likelihood of being disease-causing | | **C** | **A326V** | **Benign** | **No disease association** | | D | D417G | No classification | Insufficient evidence for assessment | ### Sequence Analysis: - **Sequence A**: No amino acid variants from reference - **Sequence B**: Contains E187G variant (glutamic acid to glycine at position 187) - **Sequence C**: Contains A326V variant (alanine to valine at position 326) - **Sequence D**: Contains D417G variant (aspartic acid to glycine at position 417) ## Evidence Supporting Sequence C as Most Likely Benign 1. **Direct ClinVar Classification**: Sequence C's A326V variant is explicitly classified as \"Benign\" in ClinVar [1] 2. **Low Disease Association**: The benign classification indicates no significant association with disease phenotypes 3. **Comparative Analysis**: - Sequence B shows \"Likely pathogenic\" classification, indicating high disease risk - Sequences A and D lack sufficient evidence for pathogenicity assessment 4. **Clinical Relevance**: ClinVar's benign classification directly addresses the question prompt ## Conclusion **Sequence C** is the most likely to be benign according to ClinVar classifications, as it is the only sequence with a direct \"Benign\" pathogenicity classification for its specific variant. --- **References:** [1] ClinVar database query results showing A326V variant classification as Benign </solution>",
  "answer_count_in_last_200_tokens": 0,
  "potential_answer_with_has_is": "Sequence C",
  "potential_answer_final_answer": null,
  "potential_answer_conclusion": "Sequence C",
  "potential_answer_emerges": null,
  "count_potential_answer_with_has_is": 5,
  "count_potential_answer_final_answer": 0,
  "count_potential_answer_conclusion": 5,
  "count_potential_answer_emerges": 0,
  "prompt": "Your task is to identify likely causal genes within a locus for a given GWAS phenotype. From the list, provide only the likely causal gene (matching one of the given genes). \nIdentify the causal gene.\nGWAS phenotype: Breast carcinoma\nGenes in locus: {ALK},{CLIP4},{FOSL2},{PCARE},{PLB1},{PPP1CB},{SPDYA},{TOGARAM2},{TRMT61B},{WDR43}\n",
  "task_name": "gwas_causal_gene_opentargets",
  "execution_time": 2706.374348640442
}